Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 2/20 | 0.47 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.47 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.47 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.47 |
| ▸ | HTR2A | P28223 | 1/20 | 0.47 |
| ▸ | SCN1A | P35498 | 1/20 | 0.47 |
| ▸ | HTR2B | P41595 | 1/20 | 0.47 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.47 |
| ▸ | SCN2A | Q99250 | 1/20 | 0.47 |
| ▸ | SCN3A | Q9NY46 | 1/20 | 0.47 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.47 |
| ▸ | USP2 | O75604 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | GNAI3 | P08754 | 4/20 | 0.44 |
| ▸ | GNAO1 | P09471 | 4/20 | 0.44 |
| ▸ | GNAI1 | P63096 | 4/20 | 0.44 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9549214 | 0.98 | GNAI3 (0.47) | MAPK1SIGMAR1ALDH1A1CYP1A2CHRM2 | |
| SCHEMBL11504373 | 0.98 | GNAI3 (0.47) | MAPK1SIGMAR1ALDH1A1CYP1A2CHRM2 | |
| SCHEMBL11504584 | 0.98 | GNAI3 (0.47) | MAPK1SIGMAR1ALDH1A1CYP1A2CHRM2 | |
| SCHEMBL3130672 | 0.93 | — | — | |
| SCHEMBL15996236 | 0.88 | GNAI3 (0.41) | MAPK1SIGMAR1ALDH1A1CYP1A2CHRM2 | |
| SCHEMBL9806563 | 0.88 | MGLL (0.41) | MAPK1SIGMAR1ALDH1A1CYP1A2CHRM2 | |
| SCHEMBL9806579 | 0.88 | MGLL (0.41) | MAPK1SIGMAR1ALDH1A1CYP1A2CHRM2 | |
| SCHEMBL40487 | 0.86 | ALDH1A1 (0.59) | MAPK1SIGMAR1ALDH1A1CYP1A2CHRM2 | |
| SCHEMBL5251269 | 0.86 | ALDH1A1 (0.59) | MAPK1SIGMAR1ALDH1A1CYP1A2CHRM2 | |
| SCHEMBL11504301 | 0.86 | SMN1; SMN2 (0.50) | MAPK1SIGMAR1ALDH1A1CYP1A2CHRM2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 51 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3262089-A1 | A PROCESS FOR PRODUCING SURFACE-POSTCROSSLINKED WATER-ABSORBENT POLYMER PARTICLES BY POLYMERIZING DROPLETS OF A MONOMER SOLUTION | BASF SE (DE) | 2018-01-03 | — | — | EP | claimed |
| WO-2016134905-A1 | A PROCESS FOR PRODUCING SURFACE-POSTCROSSLINKED WATER-ABSORBENT POLYMER PARTICLES BY POLYMERIZING DROPLETS OF A MONOMER SOLUTION | BASF SE (DE) | 2016-09-01 | — | — | WO | claimed |
| WO-2008057948-A2 | PROCESSES FOR PRODUCTION OF DIPHENYLYLAZETIDIN-2-ONES AND RELATED COMPOUNDS | IRONWOOD PHARMACEUTICALS, INC. (US) | 2008-05-15 | — | — | WO | claimed |
| EP-0175250-B1 | AGENT AND PROCESS FOR THE DETERMINATION OF REDOX SYSTEMS | Roche Diagnostics GmbH (DE) | 1990-05-09 | — | — | EP | claimed |
| EP-0175250-A2 | Agent and process for the determination of redox systems | Roche Diagnostics GmbH (DE) | 1986-03-26 | — | — | EP | claimed |
| EP-1791894-B1 | PARTICULATE WATER-ABSORBING AGENT CONTAINING WATER-ABSORBENT RESIN AS A MAIN COMPONENT | NIPPON CATALYTIC CHEM IND (JP) | 2020-10-21 | — | — | EP | disclosed |
| US-9750651-B2 | Absorbent article with profiled acquisition-distribution system | THE PROCTER & GAMBLE COMPANY (US) | 2017-09-05 | — | — | US | disclosed |
| EP-1888727-B1 | NEW DHA DERIVATIVES AND THEIR USE AS MEDICAMENTS | PRONOVA BIOPHARMA NORGE AS (NO) | 2015-04-15 | — | — | EP | disclosed |
| US-20140163504-A1 | ABSORBENT ARTICLE WITH PROFILED ACQUISITION-DISTRIBUTION SYSTEM | THE PROCTER & GAMBLE COMPANY (US) | 2014-06-12 | — | — | US | disclosed |
| US-8618165-B2 | Compounds | PRONOVA BIOPHARMA NORGE AS (NO) | 2013-12-31 | — | — | US | disclosed |
| US-20130210704-A1 | NOVEL CYCLOSPORIN DERIVATIVES AND USES THEREOF | S&T GLOBAL INC. (US) | 2013-08-15 | — | — | US | disclosed |
| EP-2258870-B1 | Method for identifying compounds which bind to biological target molecule | GLAXOSMITHKLINE LLC (US) | 2013-01-02 | — | — | EP | disclosed |
| EP-0332387-A1 | Triazole derivatives, their preparation and their use as fungicides | Sankyo Company Limited (JP) | 1989-09-13 | — | — | EP | disclosed |
| US-4820632-A | ANILINE DERIVATIVE AND OXIDIZABLE COUPLER COLORED COMPOUND FOR DETECTION OF HYDROGEN PEROXIDE; MEDICAL DIAGNOSIS | BOEHRINGER MANNHEIM GMBH (DE) | 1989-04-11 | — | — | US | disclosed |
| EP-0175250-A2 | Agent and process for the determination of redox systems | Roche Diagnostics GmbH (DE) | 1986-03-26 | — | — | EP | disclosed |
| EP-0063299-A1 | Process for the preparation of N-aryl-2,4-oxazolidine diones | BAYER AG (DE) | 1982-10-27 | — | — | EP | disclosed |
| US-4269773-A | CEPHALOSPORINS | SHIONOGI & CO., LTD. (JP) | 1981-05-26 | — | — | US | disclosed |
| US-4249931-A | 5-Oxy or thiomethyl substituted oxazolidine herbicide antidotes | STAUFFER CHEMICAL COMPANY (US) | 1981-02-10 | — | — | US | disclosed |
| EP-0011693-A1 | N-trifluoromethane-sulfonylaminophenyl-substituted N-heterocycles, their preparation, compositions containing them and their use in regulating plant growth | CIBA-GEIGY AG (CH) | 1980-06-11 | — | — | EP | disclosed |
| US-4159984-A | METAL AND PROTON DONOR | SHIONOGI & CO., LTD. (JP) | 1979-07-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130210704-A1 | NOVEL CYCLOSPORIN DERIVATIVES AND USES THEREOF | FKBP1B, MALT1, FKBP5 | MAPK1 1050/4885SIGMAR1 3999/4885ALDH1A1 2376/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.